EXAI - Exscientia plc (EXAI) Q4 2023 Earnings Call Transcript
2024-03-21 11:39:10 ET
Exscientia plc (EXAI)
Q4 2023 Results Conference Call
March 21, 2024 8:30 AM ET
Company Participants
Chinedu Okeke - Associate Director-Strategy, IR
Dave Hallett - Interim CEO, Chief Scientific Officer
Ben Taylor - CFO, Chief Strategy Officer
Mike Krams - CMO
Conference Call Participants
Alec Stranahan - Bank of America
Peter Lawson - Barclays
Vikram Purohit - Morgan Stanley
Presentation
Operator
Hello, everyone. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to Exscientia's Business Update Call for the Full Year ended 2023. [Operator Instructions].
At this time, I would like to introduce Chen Okeka, Associate Director of Strategy and Investor Relations. Chen, you may begin.
Chinedu Okeke
Thank you, operator and welcome, everyone, to Exscientia's Full Year '23 Financial Results and Business Update Conference Call. A press release and 20-F were issued this morning with our full year 2023 financial results and business update. These documents can be found on our website at investors.exscientia.ai, along with the presentation for today's webcast. Before we begin, I'd like to remind you that we may make forward-looking statements on our call. These may include statements about our projected growth, revenue, business models, preclinical and clinical results and business performance....
Exscientia plc (EXAI) Q4 2023 Earnings Call Transcript